Evaluation of the performance of a novel chemiluminescence immunoassay for cryptococcal antigen detection
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.03545-25 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Ying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy…. Hauptthemen laut MEDLINE: Antigens, Fungal, Cryptococcosis, Luminescent Measurements, Cryptococcus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
This study evaluated the diagnostic performance of a chemiluminescence immunoassay (CLIA) for detecting the Cryptococcus glucuronoxylomannan (GXM) antigen and assessed its agreement with the U.S. Food and Drug Administration (FDA)-approved IMMY lateral flow assay (LFA). From June 2021 to September 2023, a total of 651 specimens (633 cerebrospinal fluid, 18 serum) collected from 208 cryptococcosis and 415 non-cryptococcosis patients (based on diagnostic criteria for cryptococcosis) were analyzed by Dynamiker GXM antigen-CLIA platform and IMMY GXM antigen-LFA platform. Among 623 participants, the CLIA method demonstrated a total percentage agreement (TPA) of 99.52% relative to LFA. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for CLIA were 99.04, 100, 100, and 99.52%, respectively. Serial monitoring in patients receiving antifungal therapy showed a progressive decline in GXM antigen concentrations over time. The CLIA-based GXM assay exhibited high sensitivity and specificity for the diagnosing of cryptococcosis and showed close alignment with the FDA-approved LFA. It enables tracking antigen concentration changes during treatment, providing preliminary reference for therapeutic monitoring. IMPORTANCE This study demonstrates that the novel chemiluminescence immunoassay (CLIA) and the conventionally used LFA have a comparable performance in the detection of glucuronoxylomannan in cerebrospinal fluid (CSF) among patients with cryptococcosis. It enables tracking antigen concentration changes during treatment, providing preliminary reference for therapeutic monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, State Key Laboratory of Complex, Severe, and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People…
- Graduate School, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
- Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People'…
- Department of Clinical Laboratory, Beijing You'an Hospital, Capital Medical University, Beijing, People's Republic of China.
- Department of Infectious Diseases, Sir Run Run Shaw Hospital affiliated with Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
- Department of Laboratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
ORCID-Profile: Ying Zhao, Yunsong Yu, Lina Guo
Förderung
- National High Level Hospital Clinical Research Funding
Zitieren
APA
Zhao, Y., Chen, L., Li, D., Ding, X., Yu, Y., Wang, Z., Xu, Y., & Guo, L. (2026). Evaluation of the performance of a novel chemiluminescence immunoassay for cryptococcal antigen detection. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03545-25
Vancouver
Zhao Y, Chen L, Li D, Ding X, Yu Y, Wang Z, et al. Evaluation of the performance of a novel chemiluminescence immunoassay for cryptococcal antigen detection. Microbiology Spectrum. 2026. doi:10.1128/spectrum.03545-25
BibTeX
@article{Zhao2026,
author = {Zhao, Ying and Chen, Lijiang and Li, Dingding and Ding, Xiurong and Yu, Yunsong and Wang, Zhonghao and Xu, Yingchun and Guo, Lina},
title = {Evaluation of the performance of a novel chemiluminescence immunoassay for cryptococcal antigen detection},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.03545-25}
}
EUVIMED